26 February 2018 - Deborah Wilkes
Archived
GlaxoSmithKline and RB are keeping quiet on reports that they are the only two bidders for Pfizer's Consumer Healthcare business. However, the two chief executive officers have plenty to say about their prudent approach to big consumer healthcare acquisitions.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.